BiotechTube

Cenobamate

Phase 3Recruiting
0 views this week 0 watching⚡ Active
Interest: 47/100
47
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Epilepsy, Generalized

Conditions

Epilepsy, Generalized

Trial Timeline

Jul 12, 2022 → Jan 31, 2027

NCT ID
NCT06579573

About Cenobamate

Cenobamate is a phase 3 stage product being developed by Ono Pharmaceutical for Epilepsy, Generalized. The current trial status is recruiting. This product is registered under clinical trial identifier NCT06579573. Target conditions include Epilepsy, Generalized.

What happened to similar drugs?

20 of 20 similar drugs in Epilepsy, Generalized were approved

Approved (20) Terminated (6) Active (0)
✅ZonegranEisaiApproved
✅Perampanel + PlaceboEisaiApproved
✅perampanelEisaiApproved
✅Perampanel Oral TabletEisaiApproved
✅PerampanelEisaiApproved
✅zonisamide low dose group + zonisamide high dose groupEisaiApproved
✅Zonisamide at targeted daily doses of 100-500 mg/day + Placebo administered to match targeted daily doses of 100-500 mg/dayEisaiApproved

Hype Score Breakdown

Clinical
17
Activity
15
Company
15
Novelty
0
Community
0

Clinical Trials (2)

NCT IDPhaseStatus
NCT06590896Phase 2Recruiting
NCT06579573Phase 3Recruiting

Competing Products

20 competing products in Epilepsy, Generalized

See all competitors
ProductCompanyStageHype Score
perampanelEisaiPhase 2
35
LacosamideUCBPhase 3
40
Zonisamide + PlaceboEisaiPhase 3
32
ZonegranEisaiApproved
35
perampanel + perampanelEisaiPhase 1
29
Perampanel + PlaceboEisaiApproved
35
perampanelEisaiApproved
35
E2007 + PlaceboEisaiPhase 2
35
Placebo + RufinamideEisaiPhase 3
40
E2007 (perampanel) + PlaceboEisaiPhase 2
35
Perampanel Oral TabletEisaiApproved
43
perampanelEisaiPhase 3
40
PerampanelEisaiPre-clinical
26
Zonisamide + CarbamazepineEisaiPhase 3
40
PerampanelEisaiApproved
43
Perampanel and Microgynon-30 + Perampanel and Microgynon-30EisaiPhase 1
29
PerampanelEisaiPhase 2
35
Zonisamide + PlaceboEisaiPhase 3
40
zonisamide low dose group + zonisamide high dose groupEisaiApproved
43
E2007 + E2007 + PlaceboEisaiPhase 2
35